Our research strengths include cancer genomics, DNA damage, RNA biology, and drug development. We are developing expertise in drug delivery, with a focus on the nanotechnology-driven delivery of small RNA mimics and inhibitors.
Translating today's discoveries in childhood cancer research into tomorrow's treatments.
Greehey Children’s Cancer Research Institute is only one of two institutes in the United States dedicated solely to pediatric cancer research. Its 20 laboratories focus their strengths in cancer genomics, DNA repair, RNA biology, and drug development on finding new and less toxic treatments for childhood cancers.
Top stories
News
Events
-
Greehey CCRI Seminar Series, Spring ’24:Alberto Ciccia, PhD (Columbia University)
Presentation title: "Investigating the DNA damage response at high resolution" -
Greehey CCRI Seminar Series, Spring ’24: Peter Cole, MD (Rutgers)
Presentation title: "Reducing organ dysfunction after curative therapy for childhood acute lymphoblastic leukemia” -
Greehey CCRI Seminar Series, Spring ’24: Ben E. Black, Ph.D. (University of Pennsylvania)
Presentation title: Learning About Mammalian Chromosomes And Building New Ones